PTK787/ZK222584

vatalanib

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PTK787/ZK222584, covering 2009-01-23 to 2013-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors [Phase 1]